Evidence map›Paper›PMID 20428246›Full record

ArticlePloS one2010

Mutations in AKAP5 disrupt dendritic signaling complexes and lead to electrophysiological and behavioral phenotypes in mice.

Michael Weisenhaus, Margaret L Allen, Linghai Yang, Yuan Lu, C Blake Nichols, Thomas Su, Johannes W Hell, G Stanley McKnight

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. GPCR signaling via cAMP nanodomains.The Biochemical journal · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. LRBA is essential for urinary concentration and body water homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Phosphorylation-Dependent Regulation of CaFrontiers in synaptic neuroscience · 2020
    Article
  19. Transcriptional control of lung alveolar type 1 cell development and maintenance by NK homeobox 2-1.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  20. Preferential generation of CaThe Journal of biological chemistry · 2019
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Michael WeisenhausDepartment of Pharmacology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Margaret L Allen
Linghai Yang
Yuan Lu
C Blake Nichols
Thomas Su
Johannes W Hell
G Stanley McKnight
University of Washington · USUniversity of California, Davis · US

Funding

REGULATION OF CYCLIC AMP-DEPENDENT PROTEIN KINASE GENESR01GM032875 · NIGMS · UNIVERSITY OF WASHINGTON · PI MCKNIGHT, GEORGE STANLEY · 1985 to 2017
$6.0M
POSTSYNAPTIC SIGNALING PATHWAYSR01NS035563 · NINDS · UNIVERSITY OF WISCONSIN MADISON · PI HELL, JOHANNES W · 1997 to 2010
$3.1M
NIGMS NIH HHS GM 032875NIGMS NIH HHS R01 GM032875NINDS NIH HHS NS035563NINDS NIH HHS R01 NS035563
6 · The paper itself

Abstract

AKAP5 (also referred to as AKAP150 in rodents and AKAP79 in humans) is a scaffolding protein that is highly expressed in neurons and targets a variety of signaling molecules to dendritic membranes. AKAP5 interacts with PKA holoenzymes containing RIIalpha or RIIbeta as well as calcineurin (PP2B), PKC, calmodulin, adenylyl cyclase type V/VI, L-type calcium channels, and beta-adrenergic receptors. AKAP5 has also been shown to interact with members of the MAGUK family of PSD-scaffolding proteins including PSD95 and SAP97 and target signaling molecules to receptors and ion channels in the postsynaptic density (PSD). We created two lines of AKAP5 mutant mice: a knockout of AKAP5 (KO) and a mutant that lacks the PKA binding domain of AKAP5 (D36). We find that PKA is delocalized in both the hippocampus and striatum of KO and D36 mice indicating that other neural AKAPs cannot compensate for the loss of PKA binding to AKAP5. In AKAP5 mutant mice, a significant fraction of PKA becomes localized to dendritic shafts and this correlates with increased binding to microtubule associated protein-2 (MAP2). Electrophysiological and behavioral analysis demonstrated more severe deficits in both synaptic plasticity and operant learning in the D36 mice compared with the complete KO animals. Our results indicate that the targeting of calcineurin or other binding partners of AKAP5 in the absence of the balancing kinase, PKA, leads to a disruption of synaptic plasticity and results in learning and memory defects.

Indexed as

A Kinase Anchor ProteinsAnimalsBinding SitesCorpus StriatumCyclic AMP-Dependent Protein KinasesDendritesElectrophysiological PhenomenaHippocampusLearning DisabilitiesMemory DisordersMiceMice, KnockoutMicrotubule-Associated ProteinsNeuronal PlasticityProtein BindingSignal TransductionAkap5 protein, mouseA Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesMicrotubule-Associated ProteinsMtap2 protein, mouse

Identifiers

PMID20428246
PMCPMC2859064
OpenAlexW2123408996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.